Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Correcting Independent 3rd-Party "Misinformation" About Prescription Drugs
Eliminate the "Influence Prong," Says Pharma Industry

Influence ProngIt took the FDA more than four and one-half years to finally issue two social media guidance documents in June, 2014, that addressed the major issues discussed at the 2009 public hearing hearing on regulating the "Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools."

This article summarizes the industry's response to the second guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media.

Topics include (partial list):
  • What is "Misinformation?"
  • The Influence Prong
  • What is UGC?
  • Don't Chill Our Speech, Dude!
  • Wikipedia's "Bright Line Rule"
  • Hiring Agents to Make Edits
  • Chart: A Process for Correcting Wikipedia Information
  • The "One-Click Rule" Lives On!
Download the full text PDF file here:

Issue: Vol. 13, No. 9: October 2014

Find other articles in related Topic Areas:

Vol 13, #9 Contents

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.